- Report
- January 2026
- 377 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 382 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 193 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 171 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 194 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 126 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 382 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 183 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 153 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 193 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- January 2026
- 590 Pages
Global
From €5204EUR$5,850USD£4,516GBP
- Report
- December 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- October 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer.
Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes.
Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more